Coexpression of HHLA2 and PD-L1 on Tumor Cells Independently Predicts the Survival of Spinal Chordoma Patients

BACKGROUND: Immunotherapy only achieves efficacy in some cancer patients, and less is known about other immune checkpoint molecules in chordoma. Here, we aimed to determine the expression of PD-L1, HHLA2, B7H3, IDO-1 and Galectin-9 in spinal chordoma and evaluated their association with tumor infilt...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Chao, Huang, Wei, Chen, Yun-Liang, Fu, Hai-Bin, Tang, Ming, Zhang, Tao-Lan, Li, Jing, Lv, Guo-Hua, Yan, Yi-Guo, Ouyang, Zhi-Hua, Yao, Nvzhao, Wang, Cheng, Zou, Ming-Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824251/
https://www.ncbi.nlm.nih.gov/pubmed/35145510
http://dx.doi.org/10.3389/fimmu.2021.797407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824251/
https://www.ncbi.nlm.nih.gov/pubmed/35145510
http://dx.doi.org/10.3389/fimmu.2021.797407

Ejemplares similares